- Stocks
- Healthcare
- NYSE: TMO

Price (delayed)

$539.93

Market cap

$211.54B

P/E Ratio

28.49

Dividend/share

$1.16

EPS

$18.95

Enterprise value

$239.91B

Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry .

The company's equity rose by 15% YoY and by 3.3% QoQ

Thermo Fisher Scientific's revenue has increased by 12% YoY and by 4.1% from the previous quarter

The debt has soared by 61% YoY but it has decreased by 9% QoQ

Thermo Fisher Scientific's quick ratio has plunged by 51% YoY

TMO's EPS is down by 13% year-on-year and by 2.1% since the previous quarter

What are the main financial stats of TMO

Market
Valuations
Earnings

Shares outstanding

391.79M

Market cap

$211.54B

Enterprise value

$239.91B

Price to earnings (P/E)

28.49

Price to book (P/B)

5

Price to sales (P/S)

4.94

EV/EBIT

26.7

EV/EBITDA

20.01

EV/Sales

5.6

Revenue

$42.82B

EBIT

$8.99B

EBITDA

$11.99B

Free cash flow

$6.37B

Per share
Balance sheet
Liquidity

EPS

$18.95

Free cash flow per share

$16.24

Book value per share

$108.04

Revenue per share

$109.23

TBVPS

$78.92

Total assets

$90.58B

Total liabilities

$48.23B

Debt

$30.26B

Equity

$42.29B

Working capital

$7.1B

Debt to equity

0.72

Current ratio

1.65

Quick ratio

0.88

Net debt/EBITDA

2.37

Margins
Efficiency
Dividend

EBITDA margin

28%

Gross margin

46.6%

Net margin

17.4%

Operating margin

22.5%

Return on assets

8.5%

Return on equity

18.3%

Return on invested capital

19.4%

Return on capital employed

11.3%

Return on sales

21%

Dividend yield

0.21%

DPS

$1.16

Payout ratio

6.1%

How has the Thermo Fisher Scientific stock price performed over time

Intraday

3.25%

1 week

6.15%

1 month

-0.67%

1 year

-5.11%

YTD

-19.08%

QTD

6.46%

How have Thermo Fisher Scientific's revenue and profit performed over time

Revenue

$42.82B

Gross profit

$19.97B

Operating income

$9.64B

Net income

$7.44B

Gross margin

46.6%

Net margin

17.4%

The net margin has decreased by 23% YoY and by 6% QoQ

Thermo Fisher Scientific's operating margin has decreased by 20% YoY and by 5% from the previous quarter

Thermo Fisher Scientific's net income has decreased by 13% YoY and by 2.2% from the previous quarter

Thermo Fisher Scientific's revenue has increased by 12% YoY and by 4.1% from the previous quarter

What is Thermo Fisher Scientific's growth rate over time

What is Thermo Fisher Scientific stock price valuation

P/E

28.49

P/B

5

P/S

4.94

EV/EBIT

26.7

EV/EBITDA

20.01

EV/Sales

5.6

TMO's EPS is down by 13% year-on-year and by 2.1% since the previous quarter

The stock's price to earnings (P/E) is 11% less than its 5-year quarterly average of 31.9 and 5% less than its last 4 quarters average of 30.0

The company's equity rose by 15% YoY and by 3.3% QoQ

The P/B is 14% below the last 4 quarters average of 5.8 but 11% above the 5-year quarterly average of 4.5

The P/S is 15% below the last 4 quarters average of 5.8

Thermo Fisher Scientific's revenue has increased by 12% YoY and by 4.1% from the previous quarter

How efficient is Thermo Fisher Scientific business performance

TMO's return on invested capital is down by 40% year-on-year and by 10% since the previous quarter

TMO's ROA is down by 34% YoY and by 8% from the previous quarter

The ROE has contracted by 27% YoY and by 5% from the previous quarter

TMO's ROS is down by 23% year-on-year and by 5% since the previous quarter

What is TMO's dividend history

DPS

$1.16

Dividend yield

0.21%

Payout ratio

6.1%

Recent dividends

How did Thermo Fisher Scientific financials performed over time

The total assets is 88% greater than the total liabilities

Thermo Fisher Scientific's total liabilities has soared by 56% YoY but it has decreased by 7% from the previous quarter

Thermo Fisher Scientific's quick ratio has plunged by 51% YoY

The debt is 28% lower than the equity

The debt has soared by 61% YoY but it has decreased by 9% QoQ

Thermo Fisher Scientific's debt to equity has increased by 41% YoY but it has decreased by 11% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.